Abstracts (HTML) List of Authors

Haderer, M

E. coli bacteria trigger mucin reduction to promote a destabilized epithelial barrier in SBP

Haefeli, W

Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection

Haefeli, WE

Clomethiazole improves alcoholic fatty liver in patients admitted to the hospital for alcohol detoxification therapy

Hahn, F

Extending the reach of the ALBI score for primary hepatic malignancies: Does ALBI work for cholangiocarcinoma?
Survival prediction for patients with ICC undergoing chemotherapy: comparing tumor markers to cross-sectional imaging
Distant metastases in patients with intrahepatic cholangiocarcinoma: Does location matter?

Hajduk, J

The relevance of mitochondrial BAX re-distribution for apoptotic evasion in human hepatocellular carcinoma

Hall, R

Genes involved in hepatic cholesterol homeostasis identified as modifiers of cholestasis in Abcb4 deficient mice
Common genetic variant c.711A>T in the hepatobiliary phospholipid translocator ABCB4 as risk factor for liver fibrosis

Hall, RA

Fibroblast growth factor 21 response in a preclinical alcohol model of acute-on-chronic liver injury
Il-2, Il-22 and Rantes upregulation in a new mouse model of bacterial infection related acute-on-chronic liver injury

Hamberger, F

Pulmonary arterial hypertension leads to liver fibrosis in the SU5416/hypoxia model in rats

Hamesch, K

Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
Die Therapie mit Alpha-1-Antitrypsin (AAT) assoziiert bei AAT-Mangel mit besseren Leber-bezogenen Parametern

Hammad, S

Role of GPNMB in hepatic steatogenesis and cancer

Han, M

NK cells regulate LSEC to promote the HBV-specific T cells response

Hansmann, G

Pulmonary arterial hypertension leads to liver fibrosis in the SU5416/hypoxia model in rats

Hardtke, S

Soluble inflammatory molecules do not completely normalize despite early treatment of acute symptomatic hepatitis C

Hartmann, D

Der angiokrine HGF-Signalweg steuert die Organ- und Körpergröße sowie die Hepatozytenproliferation
Hepatic activation of FOXO3 regulates mTORC2-Akt and enhances oxidative damage-associated hepatocellular carcinogenesis

Hartmann, M

KRAS-mutated intrahepatic cholangiocarcinoma shows preferential sensitivity towards PARP-1-based interventions

Hartmann, N

Lipid droplet proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3

Hassan, R

Metabolic reprogramming in livers of mice with chronic liver disease

Häussinger, D

Effect of HE-relevant factors on GLAST clustering in cultured rat astrocytes
Neuregulin-1 down-regulates expression of ErbB3 expression in hepatoma cell lines at the level of transcription
The Hepatitis C Virus influences CXC chemokine expression of infected host cells in response to IL-1β
Whole exome sequencing analysis revealed an inherited AKR1D1 defect in twins with infantile intrahepatic cholestasis
Retrospektive Analyse des Therapieerfolgs von TIPS Anlagen und Identifikation prognostischer Parameter hierfür
The inflammatory mediators IL-1β and TNFα prevent CDCA-induced BSEP expression via induction of chemokines
Hepatocytes modify macrophage polarization by reducing the availability of active TGFβ
The G protein coupled bile acid receptor TGR5 (Gpbar1) modulates endothelin-1 signaling in liver

Hayback, J

Absence of JNK activity in hepatocytes exacerbates liver injury and fibrosis during chronic cholestasis in mice

Heeren, J

Nanoparticle-mediated peptide delivery to liver sinusoidal endothelial cells protects from CD8 T cell-driven cholangitis

Heikenwalder, M

A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
NEMO prevents hepatocarcinogenesis independently of an IKK complex function by controlling liver regeneration

Heikenwälder, M

Antioxidant-based therapy in non-alcoholic steatohepatitis (NASH) and NASH-induced hepatocellular carcinoma development
Hippo pathway effectors YAP and TAZ are opponents in the regulation of hepatic fibrosis
Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC
Oxygenation and miR138-5 p act as rheostats in APOBEC3B-mediated Hepatitis B Virus control

Heil, FJ

SEAL program – Early detection of liver fibrosis and cirrhosis by screening of the general population

Heilig, J

Neuregulin-1 down-regulates expression of ErbB3 expression in hepatoma cell lines at the level of transcription

Heim, K

TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Heine, M

Nanoparticle-mediated peptide delivery to liver sinusoidal endothelial cells protects from CD8 T cell-driven cholangitis

Heinrich, F

The alarmin IL-33 drives a ST2+ Treg-mediated anti-inflammatory immune response during immune-mediated hepatitis

Heinrich, S

HILPDA is upregulated, predicts prognosis and promotes cancer progression in hepatocellular carcinoma
TGFβ-activated kinase 1 (TAK1) is activated and predicts prognosis in hepatocellular carcinoma

Heinrichs, D

Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis
Macrophage Migration Inhibitory Factor promotes HCC progression in vivo via the receptor CD74

Heinze, I

Quantitative LC-MS-based shot gun proteomics identifies deregulated proteins in gallbladder carcinoma

Heinzmann, A

Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis

Heinzow, H

Predictive parameters and effectiveness of TIPS reduction in treatment of hepatic encephalopathy after TIPS

Helbeck, A

Hepatic steatosis in Crohn's disease: associations with anti-TNFα treatment, dysbiosis, and FGF-19.

Hellerbrand, C

Analysis of the expression and function of KIAA1199 in hepatocellular carcinoma
Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis
Expression and Function of Fibroblast Growth Factor 9 in hepatocellular carcinoma
Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatocellular Carcinoma
Expression and function of Epithelial Splicing Regulatory Protein 1 in hepatocellular carcinoma
Histone deacetylases (HDAC) expressions in HCC and functional effects of HDAC inhibitors in liver cancer cells

Hellweg, B

The G protein coupled bile acid receptor TGR5 (Gpbar1) modulates endothelin-1 signaling in liver

Helm, B

Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis

Hempel, F

Fibrocytes contribute to TAA-induced liver fibrosis in mice

Hengst, J

Soluble inflammatory molecules do not completely normalize despite early treatment of acute symptomatic hepatitis C

Hengstler, J

Intestinal dysbiosis amplifies acetaminophen induced acute liver injury
The G protein coupled bile acid receptor TGR5 (Gpbar1) modulates endothelin-1 signaling in liver

Hengstler, JG

Metabolic reprogramming in livers of mice with chronic liver disease
WISP1: A novel extracellular matrix remodeling protein in liver fibrosis

Hennings, J

Genetic or pharmacological inhibition of cyclin-dependent kinase 2 in Hepatic Stellate Cells acts anti-fibrotic
Genetic fine analysis of the pro-fibrotic and pro-carcinogenic functions of Cyclin E1 in the liver

Hensel, N

Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis
Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal
TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Herebian, D

Whole exome sequencing analysis revealed an inherited AKR1D1 defect in twins with infantile intrahepatic cholestasis

Herkel, J

Activation of the arylhydrocarbon receptor sensitizes to acetaminophen-induced acute liver failure
Aberrant expression of activation regulators CBL-B, CTLA-4 and PD-1 in intrahepatic Teff cells in autoimmune hepatitis
Systemic CD4 T cell tolerance induction in the liver depends on interferon-γ and CTLA-4
Autoimmune hepatitis in mice is enabled by insufficient deletion of autoreactive CD4 T cells and plasticity of Tregs
Nanoparticle-mediated peptide delivery to liver sinusoidal endothelial cells protects from CD8 T cell-driven cholangitis

Hermanns, H

Apoe- vs. Ldlr-KO: The genetic background determines the function of Oncostatin M in the regulation of lipid homeostasis
Glucose and metformin differentially regulate FGF19 signaling in human HepG2 cells
Suppression of bile acid-CoA:amino acid N-acyltransferase gene expression by Oncostatin M

Herrmann, S

Impact of complexity of laparoscopic liver resections on postoperative complications

Herrmann, T

Intestinal deletion of fatty acid transport protein 4 in mice increases blood chylomicrons

Herweg, J

Phenotyping non-alcoholic fatty liver disease by the gut microbiota – ready for prime time?

Hess, LU

Single cell RNA sequencing reveals naïve T cells ready for effector function in livers of Primary Sclerosing Cholangitis

Heyne, R

Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R
Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry
PNPLA3 and HSD17B13 gene variants exert opposite effects on fatty liver phenotypes: results from the FLAG cohort

Hildebrand, J

Improved Hepatogenic Differentiation of Human Adipose Tissue-derived MSCs Using a Silicone-based Cell Culture System

Hilgard, G

Long-term course of a patient with overlap hepatitis C and IgG4-related cholangitis

Hilscher, M

Epidemiologie und Auswirkungen bakterieller Infektionen bei stationären Patienten mit Leberzirrhose
Non-malignant portal vein thrombosis in liver cirrhosis – predictors of risk and the use of anticoagulation

Hinrichsen, H

Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R

Hirschfield, GM

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

Hizir, Z

Oxygenation and miR138-5 p act as rheostats in APOBEC3B-mediated Hepatitis B Virus control

Hofmann, M

HCV-specific CD4 T cells show strong Tfh functionality after DAA-mediated viral clearance
Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis
Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal
TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Hofmann, WP

PNPLA3 and HSD17B13 gene variants exert opposite effects on fatty liver phenotypes: results from the FLAG cohort

Hohenester, S

Hydrophobe Gallensäuren wirken durch PI3K-abhängige Proliferation von Sternzellen pro-fibrotisch

Hohmann, N

Clomethiazole improves alcoholic fatty liver in patients admitted to the hospital for alcohol detoxification therapy

Holland, CH

Metabolic reprogramming in livers of mice with chronic liver disease

Holzer, K

HELLS is an important p53 repression target in liver cancer

Holzmann, B

A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control

Hornung, M

Lipid-loaded Hepatocytes fail to Suppress IL-4 Production by Human CD4+ iNKT Cells
In-vitro Activation and anti-viral Function of Innate NK cells in HEV Infection

Horst, AK

Pyruvate kinase M2-deficiency in T cells leads to exacerbation of ConA hepatitis and alterations of T cell polarization
Soluble CEACAM1 induces activation of STAT5, Foxp3 expression and proliferation of Tregs in DC- T cell cocultures

Horvatits, T

Vergleich der Hepatitis E Seroprävalenz und Virämie zwischen HIV- und Transplant-Patienten

Hsu, MJ

Mesenchymal stromal cells may promote lipid utilization via increment of mitochondria biogenesis in targeted hepatocytes

Hu, Q

Clinically applicable liver repopulation: the role of thymidine kinase and ganciclovir (GCV)

Hübbers, A

Genetic or pharmacological inhibition of cyclin-dependent kinase 2 in Hepatic Stellate Cells acts anti-fibrotic

Huber, JP

Blood reelin levels in the progression of chronic liver disease

Huber, S

Pyruvate kinase M2-deficiency in T cells leads to exacerbation of ConA hepatitis and alterations of T cell polarization

Huber, Y

Outcome prediction of covert hepatic encephalopathy in liver cirrhosis: comparison of four testing strategies

Hucklenbruch-Rother, E

Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming

Hüser, N

Der angiokrine HGF-Signalweg steuert die Organ- und Körpergröße sowie die Hepatozytenproliferation
Hepatic activation of FOXO3 regulates mTORC2-Akt and enhances oxidative damage-associated hepatocellular carcinogenesis

Hutchinson, J

Lipid-loaded Hepatocytes fail to Suppress IL-4 Production by Human CD4+ iNKT Cells